Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1158918

Teratoma growth retardation by HDACi treatment of the tumor embryonal source


Krasić, Jure; Škara, Lucija; Ulamec, Monika; Katušić Bojanac, Ana; Dabelić, Sanja; Bulić-Jakuš, Floriana; Ježek, Davor; Sinčić, Nino
Teratoma growth retardation by HDACi treatment of the tumor embryonal source // Cancers, 12 (2020), 11; 3416, 23 doi:10.3390/cancers12113416 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1158918 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Teratoma growth retardation by HDACi treatment of the tumor embryonal source

Autori
Krasić, Jure ; Škara, Lucija ; Ulamec, Monika ; Katušić Bojanac, Ana ; Dabelić, Sanja ; Bulić-Jakuš, Floriana ; Ježek, Davor ; Sinčić, Nino

Izvornik
Cancers (2072-6694) 12 (2020), 11; 3416, 23

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
HDACi ; TGCT ; epigenetics ; cancer stem cells ; valproate ; Trichostatin A

Sažetak
Among testicular germ cell tumors, teratomas may often be very aggressive and therapy-resistant. Our aim was to investigate the impact of histone deacetylase inhibitors (HDACi) on the in vitro growth of experimental mouse teratoma by treating their embryonic source, the embryo-proper, composed only of the three germ layers. The growth of teratomas was measured for seven days, and histopathological analysis, IHC/morphometry quantification, gene enrichment analysis, and qPCR analysis on a selected panel of pluripotency and early differentiation genes followed. For the first time, within teratomas, we histopathologically assessed the undifferentiated component containing cancer stem cell-like cells (CSCLCs) and differentiated components containing numerous lymphocytes. Mitotic indices were higher than apoptotic indices in both components. Both HDACi treatments of the embryos-proper significantly reduced teratoma growth, although this could be related neither to apoptosis nor proliferation. Trichostatin A increased the amount of CSCLCs, and upregulated the mRNA expression of pluripotency/stemness genes as well as differentiation genes, e.g., T and Eomes. Valproate decreased the amount of CSCLCs, and downregulated the expressions of pluripotency/stemness and differentiation genes. In conclusion, both HDACi treatments diminished the inherent tumorigenic growth potential of the tumor embryonal source, although Trichostatin A did not diminish the potentially dangerous expression of cancer-related genes and the amount of CSCLC.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Krasić, Jure; Škara, Lucija; Ulamec, Monika; Katušić Bojanac, Ana; Dabelić, Sanja; Bulić-Jakuš, Floriana; Ježek, Davor; Sinčić, Nino
Teratoma growth retardation by HDACi treatment of the tumor embryonal source // Cancers, 12 (2020), 11; 3416, 23 doi:10.3390/cancers12113416 (međunarodna recenzija, članak, znanstveni)
Krasić, J., Škara, L., Ulamec, M., Katušić Bojanac, A., Dabelić, S., Bulić-Jakuš, F., Ježek, D. & Sinčić, N. (2020) Teratoma growth retardation by HDACi treatment of the tumor embryonal source. Cancers, 12 (11), 3416, 23 doi:10.3390/cancers12113416.
@article{article, author = {Krasi\'{c}, Jure and \v{S}kara, Lucija and Ulamec, Monika and Katu\v{s}i\'{c} Bojanac, Ana and Dabeli\'{c}, Sanja and Buli\'{c}-Jaku\v{s}, Floriana and Je\v{z}ek, Davor and Sin\v{c}i\'{c}, Nino}, year = {2020}, pages = {23}, DOI = {10.3390/cancers12113416}, chapter = {3416}, keywords = {HDACi, TGCT, epigenetics, cancer stem cells, valproate, Trichostatin A}, journal = {Cancers}, doi = {10.3390/cancers12113416}, volume = {12}, number = {11}, issn = {2072-6694}, title = {Teratoma growth retardation by HDACi treatment of the tumor embryonal source}, keyword = {HDACi, TGCT, epigenetics, cancer stem cells, valproate, Trichostatin A}, chapternumber = {3416} }
@article{article, author = {Krasi\'{c}, Jure and \v{S}kara, Lucija and Ulamec, Monika and Katu\v{s}i\'{c} Bojanac, Ana and Dabeli\'{c}, Sanja and Buli\'{c}-Jaku\v{s}, Floriana and Je\v{z}ek, Davor and Sin\v{c}i\'{c}, Nino}, year = {2020}, pages = {23}, DOI = {10.3390/cancers12113416}, chapter = {3416}, keywords = {HDACi, TGCT, epigenetics, cancer stem cells, valproate, Trichostatin A}, journal = {Cancers}, doi = {10.3390/cancers12113416}, volume = {12}, number = {11}, issn = {2072-6694}, title = {Teratoma growth retardation by HDACi treatment of the tumor embryonal source}, keyword = {HDACi, TGCT, epigenetics, cancer stem cells, valproate, Trichostatin A}, chapternumber = {3416} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font